1
|
Hartshorn EA, Grabenstein JD. Drug Interactions Involving Immunologic Agents Part I. Vaccine–Vaccine, Vaccine–Immunoglobulin, and Vaccine–Drug Interactions. ACTA ACUST UNITED AC 2017. [DOI: 10.1177/106002809002400114] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Information about immunologic drug interactions is needed by pharmacists to make rational drug-use decisions. Previously, reports of interactions involving vaccines, immune globulins, and immunodiagnostic reagents were widely dispersed. In this two-part review article, over 50 individual and categorical interactions are described, as are dozens of vaccine–vaccine and vaccine–immunoglobulin combinations for which interactions have been demonstrated not to occur. Vaccine–vaccine, vaccine–immunoglobulin, and vaccine–drug interactions are reviewed in this first part. Vigilance by all pharmacists is needed to detect previously unreported immunologic drug interactions and to further assess known interactions.
Collapse
Affiliation(s)
- Edward A. Hartshorn
- College of Pharmacy, University of Texas, Austin, and University of Texas Health Science Center, San Antonio, TX 78284
| | - John D. Grabenstein
- U.S. Army Hospital–Bremerhaven (West Germany); he is now a graduate student at the University of North Carolina School of Pharmacy, Chapel Hill, NC
| |
Collapse
|
2
|
Liberman DF, Roti Roti JL, Lange CS. Specific G2 phase toxicity of chloramphenicol on mouse leukemic cells (L5178Y). Exp Cell Res 1973; 77:351-5. [PMID: 4120439 DOI: 10.1016/0014-4827(73)90587-9] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]
|